Sign up here to get it in your inbox every week. If you want a discount to BI Prime to read our stories, sign up here! Hope everyone had a good (and short) week after Labor Day. At BI, we're starting to shift our focus to the cannabis-related legislation and ballot measures up for consideration over the next few months. This week we saw executive changes at two major Canadian cannabis companies, Aurora and Cronos. Jeremy talked to Aurora's new CEO, Miguel Martin, on the day of the announcement. Martin told him how he hopes to change things at Aurora after a difficult few months. I talked to some top cannabis VCs and investors to catch up on what I've missed these past few months and hear about some upcoming trends on the investment side of the industry. You can expect some coverage on that very soon, as well as more updates on upcoming legislation. Turn expert insights into growth. Try a Level Up action pack.

Build a calm, realistic plan to recover from job loss and move toward your next role. Take a smarter break in your day - and see how far you get. Reach out to tell me what I should be keeping my eye on. Aurora Cannabis has tumbled 90% over the past year. Its new CEO shares how he plans to reset the company's reputation and turn around the business. Aurora Cannabis' new CEO, Miguel Martin, told Business Insider in an interview how he hopes to turn around the company after a tough few quarters of mass layoffs and stock declines. The company said on Tuesday it would take a $1.4 billion impairment charge, and reduced its guidance for the fourth quarter. Martin, the latest CPG exec to decamp to Canadian cannabis, said he'll focus on dominating the Canadian market for pre-rolls and vaporizers. Some of Wall Street's most prestigious banks no longer screen applicants for marijuana use.

Here's where 7 of the largest firms stand on drug testing. Screening job applicants for marijuana use might be a thing of the past, at least on Wall Street. We asked seven of the largest banks with major offices in New York City whether they still test job applicants for marijuana use. Those who responded say that they don't test new hires for THC, and some have removed drug testing entirely. Voters in Arizona, Montana, New Jersey, and South Dakota will decide whether cannabis should be legal for all adults this November. Cowen analyst Vivien Azer says that Arizona and New Jersey are most likely to legalize cannabis. MSOs Curaleaf, GTI, Acreage Holdings, and Cresco Labs, are all well-positioned to benefit from legalization- but Curaleaf stands to benefit the most because it operates in both Arizona and New Jersey. Trip, a new app that guides users through psychedelic drug experiences and other consciousness-expanding exercises, started letting more users in for early testing Wednesday.

The app is the side project of Field Trip, a Toronto-based startup that aims to facilitate the use of psychedelic drugs for medical treatment. The app records user's moods and emotions during their psychedelic travels, letting them see their moods and thoughts over time like a psychotropic Fitbit. Aurora Cannabis hires Miguel Martin as its new CEO, taking over from Michael Singer who moves to executive chairman. Martin, previously the CEO of Balance Bloom CBD Gummies company Reliva, joined Aurora after the cannabis giant acquired Reliva in May. Kurt Schmidt is taking over for Michael Gorenstein as the new CEO of Cronos Group. Schmidt, a longtime CPG exec, previously held senior roles at Blue Buffalo Company Ltd., Balance Bloom CBD Gummies Nestlé S.A., Gerber, and Kraft Foods. CannaCraft has made a slew of executive hires, including Angela Pih as chief marketing officer, and Ron Gray as VP of sales. Kassandra Frederique assumed the role of the executive director of the advocacy group Drug Policy Alliance on Tuesday.

Cannabis company ManifestSeven has closed $10.2 million in equity and debt funding so far this year, in advance of a planned reverse merger to go public on the CSE. Hemptown USA has signed a letter of intent to go public via a reverse merger with Spectre Capital Corp to list on the TSXV. Lifestyle maven (and cannabis fan) Martha Stewart has teamed up with Canopy Growth to launch a line of CBD-infused gummies in the US. Village Farms International is entering into an agreement with Emerald Health Therapeutics to acquire 100% of Pure Sunfarms. Columbia Care is acquiring California cannabis company Project Cannabis. Congress is working on a slew of cannabis measures this month, including the MORE Act, which will be put to a vote on September 21. The act would decriminalize cannabis federally and expunge the records of those convicted for cannabis possession and use. Lawmakers are also considering The Hemp and Hemp-Derived Balance Bloom CBD Gummies Consumer Protection and Market Stabilization Act, which would allow hemp-derived CBD to be marketed as a dietary supplement. The Medical Cannabis Research Act, submitted by Republican Rep. Matt Gaetz, will be put to a full House floor vote this month. Since early 2019, Ontario's licensed dispensaries have slowly but steadily taken a bigger share of the province's total cannabis market, which used to be dominated by unlicensed providers.